D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COLI
2476
DELISTED
Colicity Inc. Class A Common Stock
COLI
| $3.01M | ﹤0.01% |
307,958
+272,665
| +773% | +$2.65M |
|
|
RDFN
2477
PUT
DELISTED
Redfin
RDFN
| $3.01M | ﹤0.01% |
+60,000
| New | +$3.24M |
|
|
NTUS
2478
DELISTED
Natus Medical Inc
NTUS
| $3.01M | ﹤0.01% |
119,874
-19,649
| -14% | -$501K |
|
2479
CALL
Estee Lauder
EL
$30.4B
| $3M | ﹤0.01% |
10,000
| – | – |
|
|
RDUS
2480
DELISTED
Radius Health, Inc.
RDUS
| $3M | ﹤0.01% |
241,644
-98,022
| -29% | -$1.41M |
|
2481
CALL
Nexstar Media Group
NXST
$6.01B
| $2.99M | ﹤0.01% |
19,700
| – | – |
|
2482
Hanover Insurance
THG
$8.13B
| $2.99M | ﹤0.01% |
23,093
-2,832
| -11% | -$386K |
|
|
GIIX
2483
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
| $2.99M | ﹤0.01% |
304,388
+204,388
| +204% | +$2.01M |
|
2484
Harmonic Inc
HLIT
$1.15B
| $2.99M | ﹤0.01% |
341,521
+200,730
| +143% | +$1.8M |
|
2485
CALL
Cintas
CTAS
$86.6B
| $2.97M | ﹤0.01% |
+31,200
| New | +$3.05M |
|
2486
PUT
Nutrien
NTR
$33.9B
| $2.97M | ﹤0.01% |
45,800
| – | – |
|
|
SVFB
2487
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
| $2.97M | ﹤0.01% |
302,354
+134,013
| +80% | +$1.32M |
|
|
SBNY
2488
CALL
DELISTED
Signature Bank
SBNY
| $2.97M | ﹤0.01% |
10,900
+1,300
| +14% | +$326K |
|
2489
CVB Financial
CVBF
$4.02B
| $2.96M | ﹤0.01% |
145,535
+96,455
| +197% | +$1.9M |
|
|
ACKIT
2490
DELISTED
Ackrell SPAC Partners I Co Subunits
ACKIT
| $2.96M | ﹤0.01% |
294,280
+106,071
| +56% | +$1.06M |
|
2491
Darden Restaurants
DRI
$24.3B
| $2.96M | ﹤0.01% |
19,512
-579,255
| -97% | -$85.1M |
|
2492
CALL
Aon
AON
$80.6B
| $2.94M | ﹤0.01% |
+10,300
| New | +$2.77M |
|
2493
CALL
Genuine Parts
GPC
$17.9B
| $2.93M | ﹤0.01% |
24,200
| – | – |
|
|
NXGN
2494
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.93M | ﹤0.01% |
207,662
+24,465
| +13% | +$381K |
|
2495
PUT
SSR Mining
SSRM
$5.19B
| $2.92M | ﹤0.01% |
+201,000
| New | +$3.19M |
|
2496
CALL
HDFC Bank
HDB
$123B
| $2.92M | ﹤0.01% |
80,000
| – | – |
|
|
NOGN
2497
DELISTED
Nogin, Inc. Common Stock
NOGN
| $2.92M | ﹤0.01% |
+14,799
| New | +$2.92M |
|
2498
Atossa Therapeutics
ATOS
$23M
| $2.92M | ﹤0.01% |
+59,737
| New | +$3.48M |
|
|
LLAP
2499
DELISTED
Terran Orbital Corporation
LLAP
| $2.92M | ﹤0.01% |
300,243
+199,807
| +199% | +$1.94M |
|
2500
PUT
ArcelorMittal
MT
$49.5B
| $2.91M | ﹤0.01% |
96,600
+48,400
| +100% | +$1.58M |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.